X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs ASTRAZENECA PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD ASTRAZENECA PHARMA STRIDES SHASUN LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 33.3 129.1 25.8% View Chart
P/BV x 0.9 19.6 4.5% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 STRIDES SHASUN LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
ASTRAZENECA PHARMA
Mar-14
STRIDES SHASUN LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2751,285 99.2%   
Low Rs918634 144.8%   
Sales per share (Unadj.) Rs389.6189.6 205.5%  
Earnings per share (Unadj.) Rs28.0-0.2 -13,736.7%  
Cash flow per share (Unadj.) Rs48.93.8 1,271.9%  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs303.168.6 441.6%  
Shares outstanding (eoy) m89.4225.00 357.7%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.85.1 55.6%   
Avg P/E ratio x39.2-4,712.7 -0.8%  
P/CF ratio (eoy) x22.4249.6 9.0%  
Price / Book Value ratio x3.614.0 25.9%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m98,03623,988 408.7%   
No. of employees `0005.81.6 372.0%   
Total wages/salary Rs m5,8811,605 366.5%   
Avg. sales/employee Rs Th6,005.93,040.2 197.5%   
Avg. wages/employee Rs Th1,014.01,029.2 98.5%   
Avg. net profit/employee Rs Th431.2-3.3 -13,206.8%   
INCOME DATA
Net Sales Rs m34,8344,740 734.9%  
Other income Rs m1,68692 1,830.4%   
Total revenues Rs m36,5204,832 755.8%   
Gross profit Rs m6,428-130 -4,952.2%  
Depreciation Rs m1,872101 1,849.3%   
Interest Rs m2,2690-   
Profit before tax Rs m3,973-139 -2,860.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,006139 -724.0%   
Tax Rs m4705 9,233.8%   
Profit after tax Rs m2,501-5 -49,133.6%  
Gross profit margin %18.5-2.7 -673.8%  
Effective tax rate %11.8-3.7 -322.8%   
Net profit margin %7.2-0.1 -6,685.4%  
BALANCE SHEET DATA
Current assets Rs m38,1652,726 1,399.8%   
Current liabilities Rs m30,4022,435 1,248.5%   
Net working cap to sales %22.36.1 362.5%  
Current ratio x1.31.1 112.1%  
Inventory Days Days7774 104.9%  
Debtors Days Days10441 256.3%  
Net fixed assets Rs m37,6391,035 3,635.6%   
Share capital Rs m89450 1,788.4%   
"Free" reserves Rs m26,210942 2,781.2%   
Net worth Rs m27,1051,716 1,579.5%   
Long term debt Rs m16,3770-   
Total assets Rs m81,1684,156 1,953.0%  
Interest coverage x2.8NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.1 37.6%   
Return on assets %5.9-0.1 -4,798.6%  
Return on equity %9.2-0.3 -3,110.7%  
Return on capital %12.10-  
Exports to sales %05.7 0.0%   
Imports to sales %06.5 0.0%   
Exports (fob) Rs mNA270 0.0%   
Imports (cif) Rs mNA306 0.0%   
Fx inflow Rs m13,465375 3,594.5%   
Fx outflow Rs m4,076470 866.9%   
Net fx Rs m9,389-96 -9,826.7%   
CASH FLOW
From Operations Rs m2,881-8 -35,572.8%  
From Investments Rs m-7,051-146 4,839.5%  
From Financial Activity Rs m3,382862 392.3%  
Net Cashflow Rs m-788709 -111.2%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 37.8 0.3 12,600.0%  
FIIs % 8.6 15.7 54.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 9.1 284.6%  
Shareholders   56,241 12,856 437.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  TORRENT PHARMA  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Metal Stocks Drag(09:30 am)

Asian share markets slipped in the opening trade today as investors digested the escalation in trade tensions between the US and China after both countries announced tariffs last week.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jun 18, 2018 11:31 AM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS